Emergent BioSolutions (EBS) Free Cash Flow (2010 - 2026)
Emergent BioSolutions (EBS) posted Free Cash Flow of $54.0 million for Q2 2026, up 249.17% on a QoQ basis from -$36.2 million in Q1 2026, and down 47.83% year-over-year from $103.5 million in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Free Cash Flow (2010 - 2026) Analysis & Trends
Emergent BioSolutions has reported Free Cash Flow for 17 years, with the latest figure at $54.0 million in Q2 2026.
- On a quarterly basis, Free Cash Flow fell 47.83% year-over-year to $54.0 million in Q2 2026; TTM through Jun 2026 was $85.9 million, a 44.58% decrease from a year earlier, with the FY2025 full-year figure at $156.8 million, up 337.99% from the prior year.
- Free Cash Flow was $54.0 million for Q2 2026 at Emergent BioSolutions, up from -$36.2 million in the prior quarter.
- The five-year high for Free Cash Flow was $147.9 million in Q3 2024, with the low at -$253.4 million in Q3 2022.
- Average Free Cash Flow over 5 years is -$18.1 million, with a median of -$10.2 million recorded in 2025.
- The sharpest annual moves came in 2022 and 2024: Free Cash Flow sank 558.18% in 2022, then jumped 212.03% in 2024.
- Over 5 years, Free Cash Flow stood at $92.8 million in 2022, then sank by 77.69% to $20.7 million in 2023, then plunged by 494.2% to -$81.6 million in 2024, then surged by 190.44% to $73.8 million in 2025, then retreated by 26.83% to $54.0 million in 2026.
- The last three Free Cash Flow figures came in at $54.0 million (Q2 2026), -$36.2 million (Q1 2026), and $73.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | 7.30 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | 3.11 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | 4.48 Bn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | 6.20 Bn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | 302.00 Mn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | 3.09 Bn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | 3.44 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | 437.80 Mn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | -389.61 Mn |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | 54.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 54.00 Mn |
| Mar 31, 2026 | -36.20 Mn |
| Dec 31, 2025 | 73.80 Mn |
| Sep 30, 2025 | -5.70 Mn |
| Jun 30, 2025 | 103.50 Mn |
| Mar 31, 2025 | -14.80 Mn |
| Dec 31, 2024 | -81.60 Mn |
| Sep 30, 2024 | 147.90 Mn |
| Jun 30, 2024 | 42.90 Mn |
| Mar 31, 2024 | -73.40 Mn |
| Dec 31, 2023 | 20.70 Mn |
| Sep 30, 2023 | 47.40 Mn |
| Jun 30, 2023 | -126.90 Mn |
| Mar 31, 2023 | -199.10 Mn |
| Dec 31, 2022 | 92.80 Mn |
| Sep 30, 2022 | -253.40 Mn |
| Jun 30, 2022 | -47.70 Mn |
| Mar 31, 2022 | -69.50 Mn |
| Dec 31, 2021 | 282.30 Mn |
| Sep 30, 2021 | -38.50 Mn |
API Access
Emergent BioSolutions Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();